138 related articles for article (PubMed ID: 17023235)
1. Controlled-release carvedilol: a concluding perspective.
Packer M
Am J Cardiol; 2006 Oct; 98(7A):67L-69L. PubMed ID: 17023235
[No Abstract] [Full Text] [Related]
2. Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. Introduction.
Sica DA
Am J Cardiol; 2006 Oct; 98(7A):1L-4L. PubMed ID: 17023226
[No Abstract] [Full Text] [Related]
3. Controlled-release carvedilol.
Carter NJ; Keating GM
Am J Cardiovasc Drugs; 2008; 8(4):271-82. PubMed ID: 18690761
[No Abstract] [Full Text] [Related]
4. Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict beta1-blockade in patients with congestive heart failure.
Tenero DM; Henderson LS; Campanile AM; Baidoo CA; Boyle D
Am J Cardiol; 2006 Oct; 98(7A):27L-31L. PubMed ID: 17023229
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic properties of a new controlled-release formulation of carvedilol.
Tenero DM; Henderson LS; Baidoo CA; Harter AH; Campanile AM; Danoff TM; Boyle D
Am J Cardiol; 2006 Oct; 98(7A):5L-16L. PubMed ID: 17023227
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
[TBL] [Abstract][Full Text] [Related]
7. Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study.
Kim YH; Choi HY; Noh YH; Lee SH; Lim HS; Kim C; Bae KS
Drug Des Devel Ther; 2015; 9():2911-8. PubMed ID: 26089641
[TBL] [Abstract][Full Text] [Related]
8. Role of carvedilol controlled-release in cardiovascular disease.
Fonarow GC
Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol [Coreg].
Kukin M
Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
[No Abstract] [Full Text] [Related]
10. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
11. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
Tereshchenko SN; Zhirov IV
Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
[No Abstract] [Full Text] [Related]
12. Carvedilol outclasses the other beta-blockers.
Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
[No Abstract] [Full Text] [Related]
13. Carvedilol.
Frishman WH
Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
[No Abstract] [Full Text] [Related]
14. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
15. [Carvedilol].
Antepohl W; Herzig S; Böhm M
Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
[No Abstract] [Full Text] [Related]
16. Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure.
Hauptman PJ; Pressler SJ; Sackner-Bernstein J; Ordronneau P; Udelson JE;
Am J Cardiol; 2006 Oct; 98(7A):60L-66L. PubMed ID: 17023234
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
[TBL] [Abstract][Full Text] [Related]
18. Effect of carvedilol on seizure induction during electroconvulsive therapy procedure.
Syed N
J ECT; 2009 Mar; 25(1):60. PubMed ID: 18978602
[No Abstract] [Full Text] [Related]
19. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
Greenberg BH; Mehra M; Teerlink JR; Ordronneau P; McCollum D; Gilbert EM
Am J Cardiol; 2006 Oct; 98(7A):53L-59L. PubMed ID: 17023233
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol.
Frishman WH
N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
